The phrase "expensive end" is grammatically correct and can be used in written English.
It can be used to describe the more expensive or higher-priced option in a comparison or to refer to the more expensive part of something. Example: "I can't afford to buy a new car right now, but I can definitely afford the cheaper end of the used car market. The expensive end is just out of my budget." In this example, "expensive end" is used to refer to the more expensive options in the used car market. It can also be used in a similar way when talking about price ranges for other products or services.
At the least expensive end of the spectrum are books.
'It's all bedroom, bath and kitchen - at the expensive end.
Even at this less expensive end of the business, flying privately is not cheap.
He said the "financial tide drags to the expensive end of the system".
At the most expensive end of the scale are gas condensing boilers.
Still, the action in the expensive end of the market was fast and furious.
10 30 A.M. (13) RELIGION & ETHICS NEWSWEEKLY In the first segment of a two-part series on containing Medicare costs, Betty Rollin interviews doctors and ethicists about the problem of aggressive and expensive end-of-life medical care and its effects on patients and their families.
Costs and Benefits This "incredibly expensive end-of-life care" detracts from the health care system's ability to finance preventive care, Dr. Charles A. Bush, the medical director of Richard M. Ross Heart Hospital at the Ohio State University, told me.
They point to a competing University of Pittsburgh study, which found that patients tend to live longer in hospitals that provide lots of expensive end-of-life procedures.
Approval of expensive end-of-life treatment has been increasingly debated in the last years and a supplement to the National Institute for Health and Care Excellence guidelines on technology appraisal was written to allow approval of very restricted end-of-life medicines exceeding conventional threshold levels of £20-30,000 per quality-adjusted life years (QALY) [ 12].
Faden et al., who had a similar point of view, compared the UK and US experiences with expensive cancer drugs, and found that the UK system is fairer and better structured than the US system when dealing with difficult decisions about expensive end-of-life cancer drugs [ 38].
